Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Minimally Invasive Surgery Option Preferable for Stomach Cancer Patients

By HospiMedica International staff writers
Posted on 30 Apr 2009
An innovative, minimally invasive surgical approach to treat stomach cancer has been shown to have advantages that may make it a preferable treatment for some patients, according to a new study.

Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC; New York, NY, USA) conducted a case-controlled study in patients with adenocarcinoma selected from a prospective gastric cancer database. More...
Thirty consecutive patients undergoing laparoscopic subtotal gastrectomy were compared with 30 patients undergoing open subtotal gastrectomy. Controls were matched for stage, age, and gender via a statistically generated selection of all gastrectomies performed during the same period of time. Patient demographics, tumor-node-metastasis (TNM) stage, histologic features, location of tumor, lymph node retrieval, recurrence, margins, and early and late postoperative complications were compared.

The study results showed that tumor location and histology were similar between the two groups. Median operative time for the laparoscopic approach was 270 minutes, compared with a median of 126 minutes in the open group. Hospital stay after laparoscopic gastrectomy was 5 days, compared with 7 days in the open group. Postoperative pain, as measured by number of days of intravenous (IV) narcotic use, was significantly lower for laparoscopic patients, with a median of 3 days, compared with 4 days in the open group. Postoperative early complications trended towards a decrease for laparoscopic versus open surgery patients, but there were also significantly more late complications for the open group. Short-term recurrence-free survival and margin status was similar between the two groups, with adequate lymph node retrieval in both groups.

"Our number one goal in treating patients with stomach cancer is to remove the cancer completely and safely, while preserving his or her quality of life," said lead author Vivian Strong, M.D., of the department of surgery. "Laparoscopic gastrectomy is an excellent option for certain patients with the disease, and for those patients, this approach has the same success rate as standard open surgery, with significantly fewer complications.”

According to the authors, an additional benefit seen among the patients who underwent laparoscopic gastrectomy was that this approach still enabled adequate lymph node retrieval to determine whether the cancer had spread, as well as parallel examination of other oncologic features of the resection.

Related Links:
Memorial Sloan-Kettering Cancer Center



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.